The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Abstract
BACKGROUND: Primary sclerosing cholangitis (PSC) is strongly associated with inflammatory bowel disease (IBD). The aim of this study was to assess the IBD phenotype associated with PSC in a large well-phenotyped population-based PSC cohort using endoscopic and histopathologic criteria. METHODS: PSC cases were identified and ascertained, fulfilling well-established criteria, in 39 hospitals in a geographically defined region of The Netherlands. IBD location was recorded according to the Montreal Classification. As this classification does not consider segmental inflammation, backwash ileitis, or rectal sparing, an additional subgroup analysis was performed in 80 cases and 80 age- and sex-matched IBD controls, reviewing all endoscopy and pathology reports filed between 2000 and 2010. RESULTS: In all, 380 (66%) of a total of 579 PSC patients had coexistent IBD, mainly ulcerative colitis (UC) (75%). Overall, 207 (83%) of the PSC-UC patients had a pancolitis, 32 (13%) a left-sided colitis, and 9 (4%) a proctitis only. Seventy (95%) PSC-Crohn's disease (CD) patients had an (ileo)colitis and four (5%) ileitis only. In the subgroup analysis 53 (66%) PSC-UC patients were identified, 24 (30%) PSC-CD patients, and three (4%) PSC-IBD-U patients. Fifty (94%) PSC-UC patients had a pancolitis, compared with 32 (62%) matched UC patients (P < 0.001). Left-sided colitis was seen in 16 (31%) UC controls and in one PSC-UC patient (P < 0.001). Backwash ileitis and rectal sparing were rare findings (<10%) in the cohorts under study. CONCLUSIONS: IBD in PSC patients represents a distinct phenotype in that pancolitis is observed in 94% of PSC-UC and colitis in 96% of PSC-CD patients. Backwash ileitis and rectal sparing were rare findings in the PSC-UC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Boonstra, K., Beuers, U., & Ponsioen, C. Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.025 · Cited by 632
Self-citationPardi, D. S., Loftus, E. V., Kremers, W. K., Keach, J., & Lindor, K. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50156 · Cited by 562
High lifetime risk of cancer in primary sclerosing cholangitis
Claessen, M. M. H., Vleggaar, F. P., Tytgat, K. M. A. J., Siersema, P. D., & van Buuren, H. R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.013 · Cited by 412
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
Karlsen, T. H., Franke, A., Melum, E., Kaser, A., Hov, J. R., Balschun, T., Lie, B. A., Bergquist, A., Schramm, C., Weismüller, T. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.046 · Cited by 361
Self-citationEksteen, B., Grant, A. J., Miles, A., Curbishley, S. M., Lalor, P. F., Hübscher, S. G., Briskin, M., Salmon, M., & Adams, D. H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041035 · Cited by 360
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
Adams, D. H., & Eksteen, B. (2006) · Nature Reviews Immunology · doi:10.1038/nri1784 · Cited by 307
Ponsioen, C. Y., Vrouenraets, S. M. E., Prawirodirdjo, W., Rajaram, R., Rauws, E. A. J., Mulder, C. J. J., Reitsma, J. B., Heisterkamp, S. H., & Tytgat, G. N. J. (2002) · Gut · doi:10.1136/gut.51.4.562 · Cited by 268
Self-citationMelum, E., Franke, A., Schramm, C., Weismüller, T. J., Gotthardt, D. N., Offner, F. A., Juran, B. D., Laerdahl, J. K., Labi, V., Björnsson, E., et al. (2011) · Nature Genetics · doi:10.1038/ng.728 · Cited by 256
Self-citationKornfeld, D., Ekbom, A., & Ihre, T. (1997) · Gut · doi:10.1136/gut.41.4.522 · Cited by 251
Risk factors for recurrence of primary sclerosing cholangitis of liver allograft
Vera, A., Moledina, S., Gunson, B., Hubscher, S., Mirza, D., Olliff, S., & Neuberger, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11861-7 · Cited by 231
Schrumpf, E., Fausa, O., Førre, Ø., Dobloug, J. H., Ritland, S., & Thorsby, E. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209182038 · Cited by 204
Papatheodoridis, G. V., Hamilton, M., Mistry, P. K., Davidson, B., Rolles, K., & Burroughs, A. K. (1998) · Gut · doi:10.1136/gut.43.5.639 · Cited by 189
Bergquist, A., Montgomery, S. M., Bahmanyar, S., Olsson, R., Danielsson, Å., Lindgren, S., Prytz, H., Hultcrantz, R., Lööf, L., Sandberg–Gertzén, H., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.016 · Cited by 188
Joo, M., Abreu-e-Lima, P., Farraye, F., Smith, T., Swaroop, P., Gardner, L., Lauwers, G. Y., & Odze, R. D. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318196d018 · Cited by 184
Lundqvist, K., & Broomé, U. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02258391 · Cited by 159
Jrgensen, K. K., Grzyb, K., Lundin, K. E. A., Clausen, O. P. F., Aamodt, G., Schrumpf, E., Vatn, M. H., & Boberg, K. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21699 · Cited by 149
Janse, M., Lamberts, L. E., Franke, L., Raychaudhuri, S., Ellinghaus, E., Boberg, K. M., Melum, E., Folseraas, T., Schrumpf, E., Bergquist, A. M., et al. (2011) · Hepatology · doi:10.1002/hep.24307 · Cited by 142
Self-citationRisk of colorectal neoplasia in patients with primary sclerosing cholangitis
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566590 · Cited by 136
Wolf, J. M., Rybicki, L. A., & Lashner, B. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02650.x · Cited by 131
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis
Claessen, M. M., Lutgens, M. W. M. D., van Buuren, H. R., Oldenburg, B., Stokkers, P. C. F., van der Woude, C. J., Hommes, D. W., de Jong, D. J., Dijkstra, G. D. H., Bodegraven, A. A. V., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20886 · Cited by 130
Bastida, G., Nos, P., Aguas, M., Beltrán, B., RUBÍN, Á., Dasí, F., & Ponce, J. D. C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02636.x · Cited by 122
Torres, J., de Chambrun, G. P., Itzkowitz, S. H., Sachar, D. B., & Colombel, J. F. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04753.x · Cited by 117
Marelli, L., Xirouchakis, E., Kalambokis, G. N., Cholongitas, Ε., Hamilton, M., & Burroughs, A. K. (2011) · Gut · doi:10.1136/gut.2010.235408 · Cited by 115
Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis
Broomé, U., Löfberg, R., Lundqvist, K., & VERESS, B. (1995) · Diseases of the Colon & Rectum · doi:10.1007/bf02049156 · Cited by 105
Sano, H., Nakazawa, T., Ando, T., Hayashi, K., Naitoh, I., Okumura, F., Miyabe, K., Yoshida, M., Takahashi, S., Ohara, H., et al. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0319-8 · Cited by 104
The Geoepidemiology of Primary Biliary Cirrhosis
Metcalf, J. V., & James, O. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007179 · Cited by 100
Sokol, H., Cosnes, J., Chazouillères, O., Beaugerie, L., Tiret, E., Poupon, R. Y., & Seksik, P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3497 · Cited by 99
Lindström, L., Boberg, K. M., Wikman, O., Friis–Liby, I., Hultcrantz, R., Prytz, H., Sandberg–Gertzén, H., Sangfelt, P., Rydning, A., Folvik, G., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04966.x · Cited by 85
Immunohistochemical analysis of inflammation in primary sclerosing cholangitis
Ponsioen, C. Y., Kuiper, H., ten Kate, F. J. W., de Wit, M. V. M., van Deventer, S. J. H., & Tytgat, G. N. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199907000-00015 · Cited by 73
Self-citationHo, G., Seddon, A. J., Therapondos, G., Satsangi, J., & Hayes, P. C. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200512000-00018 · Cited by 56
Cited by
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.038 · Cited by 533
Self-citationPrimary Sclerosing Cholangitis
Lazaridis, K. N., & LaRusso, N. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1506330 · Cited by 505
Metadata
- Authors
- Boonstra, K., van Erpecum, K. J., van Nieuwkerk, K. M. J., Drenth, J. P. H., Poen, A. C., Witteman, B. J. M., Tuynman, H. A. R. E., Beuers, U., & Ponsioen, C. Y.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12
- Volume
- 18
- Issue
- 12
- Pages
- 2270-2276
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2058589857
- Cited by
- 262
- References
- 32
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.